[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100271815":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":21,"responsibleParty":41,"collaborators":43,"id":49,"slug":7,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":7,"maxAge":7,"enrollmentInfo":57,"targetDuration":60,"studyType":61,"phases":7,"briefSummary":62,"conditions":63,"keywords":73,"overallStatus":23,"whyStopped":7,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"University of Pennsylvania","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Joshua Brandstadter, MD, PhD, MSc","PRINCIPAL_INVESTIGATOR",[13,17],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","267-847-8220","joshua.brandstadter@pennmedicine.upenn.edu",{"name":18,"role":14,"phone":19,"phoneExt":7,"email":20},"Bridget Austin, MSc","2675869977","accelerate@uphs.upenn.edu",[22],{"facility":5,"status":23,"city":24,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"RECRUITING","Philadelphia","Pennsylvania","19104","United States","US",{"type":30,"coordinates":31},"Point",[32,33],-75.16362,39.95238,{"lat":33,"lon":32},[36,37,39],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},{"name":18,"role":14,"phone":38,"phoneExt":7,"email":20},"267-586-9977",{"name":40,"role":11,"phone":7,"phoneExt":7,"email":7},"Joshua C Brandstadter, MD, PhD, MSc",{"type":42,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[44,47],{"name":45,"class":46},"EUSA Pharma, Inc.","INDUSTRY",{"name":48,"class":6},"Castleman Disease Collaborative Network","100271815",false,"NCT02817997","International Registry for Patients With Castleman Disease","ACCELERATE (Advancing Castleman Care With an Electronic Longitudinal Registry, E-Repository, And Treatment\u002FEffectiveness Research): An International Registry for Patients With Castleman Disease","ACCELERATE","Inclusion Criteria:\n\n* Person of any age\n* Have a reference pathology report suggesting \"Castleman disease\" not limited to cutaneous involvement only that can be uploaded\n* Be able to provide electronic informed consent, as per local regulations\n* Deceased patients may also be enrolled when a reference pathology report suggesting \"Castleman disease\" can be supplied or when the ART is able to locate and upload such a pathology report.\n\nExclusion Criteria:\n\n* Because this registry is designed to provide as wide a picture of routine clinical practice as possible, inclusion criteria are set deliberately wide and there are no exclusion criteria.","ALL",{"count":58,"type":59},1000,"ESTIMATED","10 Years","OBSERVATIONAL","The purpose of this study is to collect clinical, laboratory, and patient survey data from patients with Castleman disease to improve understanding, diagnosis, and treatment of the disease. Funding source - FDA OOPD.",[64,65,66,67,68,69,70,71,72],"Castleman Disease","Castleman's Disease","Giant Lymph Node Hyperplasia","Angiofollicular Lymph Hyperplasia","Angiofollicular Lymph Node Hyperplasia","Angiofollicular Lymphoid Hyperplasia","GLNH","Hyperplasia, Giant Lymph Node","Lymph Node Hyperplasia, Giant",[74,75,76,77,78,79,65,67,80,81],"patient registry","ACCELERATE study","CD","MCD","iMCD","Castleman","multicentric Castleman's disease","multicentric Castleman disease","2026-02-27",{"date":84,"type":85},"2026-03-03","ACTUAL",{"date":87,"type":7},"2016-10",{"date":89,"type":59},"2027-09",{"name":5,"class":6},1]